Mar 21 2025 37 mins 7
Mitochondria are famously the powerhouse of the cell, but will mitochondrial therapeutics power the next big mainstream medical breakthrough?
Klaus Dugi is CEO of Vandria, a biotech that develops mitophagy inducers that rejuvenate cells to treat age-related and chronic diseases. He joins 'Beyond Biotech' to talk cell mitophagy, biotech agility, and innovation in tackling neurodegenerative disease.
00:42 Introducing Klaus Dugi
02:51 Lessons learned in top pharma
05:10 The gap that Vandria seeks to fill
06:21 Mitochondrial therapeutics
07:45 Mitophagy inducers and how they work
14:53 Comparing approaches to treating neurodegenerative diseases
17:20 Aging, longevity, and healthy life years
25:26 Challenges ahead
27:31 Performance enhancement and resilience
31:15 Towards the mainstream?
34:35 Looking forward for Vandria
36:02 Developments to watch out for in mitochondrial therapeutics
Interested in being a sponsor of an episode of our podcast? Discover how you can get involved here!
Stay updated by subscribing to our newsletter
